Debut Plus

368.25

-5.99 -1.60%

17 Jul 2026

NSE Listed

Indraprastha Medical Corp (INDRAMEDCO)

Volume: 80,105Avg Vol 1W: 85,817.6Avg Vol 1M: 1,10,595.852W Range:342640.85
Key Ratios
Checked 3h ago
Market Cap₹3,431 Cr
Current Price₹368.25
Previous Close₹374.24
High / Low (52w)₹640.85 / ₹342
Volume80,105
Avg Vol (1W)85,817.6
Avg Vol (1M)1,10,595.8
Stock P/E82.25
Book Value₹80.76
Dividend Yield107%
ROE24.8%
ROA18.52%
Revenue (TTM)₹1,379 Cr
Revenue Growth
Profit Margin12.39%
Total Debt
Shares Outstanding9 Cr
Face Value₹10
EPS (TTM)₹20.03
P/B4.63
Debt / Equity0.06
50 DMA₹381.07
200 DMA₹433.36
Day change-1.60%
Price Chart
368.25 24.03% · 1Y
6233501.1Cr
2025-07-17
2026-07-16

20-day avg volume: 1.1L shares

Pros
  • Healthy return on equity of 24.8%.
  • Pays a dividend yield of 107.0%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 82.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹348 Cr₹350 Cr₹325 Cr₹334 Cr₹365 Cr₹381 Cr₹372 Cr₹365 Cr
EBITDA₹61 Cr₹59 Cr₹46 Cr₹57 Cr₹70 Cr₹68 Cr₹58 Cr₹57 Cr
Net Profit₹45 Cr₹42 Cr₹33 Cr₹41 Cr₹51 Cr₹49 Cr₹41 Cr₹42 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹753 Cr₹789 Cr₹831 Cr₹614 Cr₹891 Cr₹1,109 Cr₹1,262 Cr₹1,379 Cr
EBITDA₹43 Cr₹51 Cr₹54 Cr₹8 Cr₹82 Cr₹121 Cr₹170 Cr₹223 Cr
Net Profit₹21 Cr₹28 Cr₹44 Cr₹2 Cr₹59 Cr₹86 Cr₹124 Cr₹161 Cr
EPS2.33.14.760.256.399.413.5217.56
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹432 Cr₹422 Cr₹449 Cr₹432 Cr₹462 Cr₹555 Cr₹723 Cr₹852 Cr
Total Liabilities₹200 Cr₹178 Cr₹181 Cr₹159 Cr₹136 Cr₹176 Cr₹245 Cr₹255 Cr
Equity₹232 Cr₹244 Cr₹268 Cr₹273 Cr₹325 Cr₹379 Cr₹478 Cr₹597 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹36 Cr₹114 Cr₹154 Cr₹247 Cr₹218 Cr
Investing₹-19 Cr₹-74 Cr₹-108 Cr₹-158 Cr₹-111 Cr
Financing₹-3 Cr₹-3 Cr₹-26 Cr₹-32 Cr₹-46 Cr
Free Cash Flow₹36 Cr₹114 Cr₹154 Cr₹247 Cr₹218 Cr
Shareholding
Promoter 51% Institutions 3.31% Public 45.69%
Efficiency & Working Capital
ROCE32.4%
Interest Coverage35.5
Dividend Payout
Debtor Days20 d
Inventory Days2 d
Payable Days33 d
Cash Conversion Cycle-11 d
Working Capital Days22 d
Shareholding Details

As of 2026-06-30

Promoter51%
FII2.8%
DII0.6%
Institutions3.4%
Public45.6%
Promoter Pledge0%
No. of Shareholders75,098
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters51%51%51%51%51%51%51%51%51%51%51%51%
FIIs0.8%0.9%1.1%1.7%2.6%2.9%2.9%2.7%2.4%2.7%2.4%2.8%
DIIs6.7%6.4%4.9%3.2%3.2%3.2%3.6%3.6%3.5%0.8%0.9%0.6%
Public41.5%41.7%43%44.2%43.2%42.9%42.5%42.7%43.1%45.4%45.7%45.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders47,86551,44854,15855,10364,67169,69770,49170,21170,91471,22572,98075,098
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
President Of IndiaShareholding of Promoter and Promoter Group26%2.38 Cr
Apollo Hospitals Enterprise LimitedShareholding of Promoter and Promoter Group22%2.02 Cr
Vanjana Sundar IyerPublic Shareholding2%18,40,681
Emedlife Insurance Broking Services LimitedPublic Shareholding1.7%15,50,701
Wedgewood Holdings LimitedShareholding of Promoter and Promoter Group1.6%14,75,000
Citadel Research And Solutions LimitedPublic Shareholding1.3%11,74,983
Pcr Investments LimitedShareholding of Promoter and Promoter Group0.4%3,87,423
Prathap C ReddyShareholding of Promoter and Promoter Group0.3%2,37,187
Preetha ReddyShareholding of Promoter and Promoter Group0.2%2,02,650
Sucharitha P ReddyShareholding of Promoter and Promoter Group0.2%1,60,689
Suneeta ReddyShareholding of Promoter and Promoter Group0.2%1,38,293
Shobana KamineniShareholding of Promoter and Promoter Group0.1%1,16,918
Sangita ReddyShareholding of Promoter and Promoter Group0%9,900
K S BaidwanShareholding of Promoter and Promoter Group0%1
P V JayakrishnanShareholding of Promoter and Promoter Group0%1
Ramesh ChanderShareholding of Promoter and Promoter Group0%1
Vineeta RaiShareholding of Promoter and Promoter Group0%1
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Pratap C Reddy00%2026-06-30
Preetha Reddy00%2026-06-30
Sucharitha P Reddy00%2026-06-30
Suneeta Reddy00%2026-06-30
Shobana Kamineni00%2026-06-30
Sangita Reddy00%2026-06-30
K S Baidwan00%2026-06-30
P V Jayakrishan00%2026-06-30
Ramesh Chander00%2026-06-30
Vineetarai00%2026-06-30
President Of India00%2026-06-30
Apollo Hospitals Enterprises Limited00%2026-06-30
Board of Directors
NameDesignationYear
Prathap C ReddyVice Chairman2025
Suneeta ReddyNon-Exec & Non-Independent Dir2025
Sangita ReddyNon-Exec & Non-Independent Dir2025
Mahesh VermaNon Independent Non Executive Director / Nominee2025
MADHUMITA GANGULIIndependent Non Exe. Director2025
Salil SinghalIndependent Non Exe. Director2025
Vineeta RaiIndependent Non Exe. Director2025
Vinayak ChatterjeeIndependent Non Exe. Director2025
P ShivakumarED / MD / Promoter2025
Sandip SomanyIndependent Non Exe. Director2025
Tejpreet S ChopraIndependent Non Exe. Director2025
SUDHIR JALANIndependent Non Exe. Director2025
PRIYA RANJANAVP - Corporate Affairs & Legal / CS2025
Segments — Product
SegmentRevenueShare
Healthcare₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹101009292
Corporate Actions
TypeDateValueRemark
dividend2025-09-18₹4.5 (45%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20250008149157
202500001212
202500001717
Substantial Acquisitions (SAST)

1 disclosure(s)

Market29/02/2024 - 04/04/2024 · 27,81,897
Company Information
Incorporated1988
ChairmanPrathap C Reddy
AuditorS N Dhawan & Co LLP
Investor Email[email protected]
🌐 www.delhi.apollohospitals.com

📍 Sarita Vihar, Delhi-Mathura Road, New Delhi, New Delhi, 110076

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search